1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
04:11 pm
MRNA
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
High
Report
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
1/7
08:23 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
1/6
05:04 pm
MRNA
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Low
Report
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
12/12
12:16 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
12:16 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
08:24 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/12
08:24 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
12/11
07:59 pm
MRNA
Moderna initiated with a Hold at Jefferies
Low
Report
Moderna initiated with a Hold at Jefferies
12/11
07:59 pm
MRNA
Moderna initiated with a Hold at Jefferies
Low
Report
Moderna initiated with a Hold at Jefferies
11/21
01:06 pm
MRNA
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/21
09:44 am
MRNA
Rating for MRNA
Medium
Report
Rating for MRNA
11/21
09:44 am
MRNA
Rating for MRNA
Medium
Report
Rating for MRNA
11/21
09:34 am
MRNA
Rating for MRNA
Medium
Report
Rating for MRNA
11/20
04:01 pm
MRNA
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/20
04:01 pm
MRNA
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/7
10:38 am
MRNA
Rating for MRNA
Medium
Report
Rating for MRNA
11/7
10:38 am
MRNA
Rating for MRNA
Medium
Report
Rating for MRNA
10/23
04:59 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
10/23
12:17 pm
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
10/23
06:57 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA
10/23
06:57 am
MRNA
Rating for MRNA
Low
Report
Rating for MRNA